InvestorsHub Logo
Followers 8
Posts 389
Boards Moderated 0
Alias Born 02/12/2009

Re: biopharm post# 125675

Monday, 06/03/2013 11:51:44 AM

Monday, June 03, 2013 11:51:44 AM

Post# of 345950
Bio,

Thanks for the link. Now because of the following from the Roth report link:

The company outlined their entire analysis of the study discrepancies and for the entire study and the FDA did not raise any question regarding the pooling of the 1 mg/kg and control arms. Based on the data and the size of the safety database, the design was cleared to move forward,” he added.



does this mean that Peregrine is now emboldened/justified in submitting for BTD?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News